These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 9865278)
1. Specific immunosuppression of the indirect recognition pathway. Suciu-Foca N; Cortesini R Transplant Proc; 1998 Dec; 30(8):4009-10. PubMed ID: 9865278 [No Abstract] [Full Text] [Related]
2. Specific immunosuppression of the indirect recognition pathway. Suciu-Foca N; Cortesini R Transplant Proc; 1998 Dec; 30(8):4060-1. PubMed ID: 9865294 [No Abstract] [Full Text] [Related]
3. Persistent allopeptide reactivity and epitope spreading in chronic rejection. Suciu-Foca N; Ciubotariu R; Liu Z; Ho E; Rose EA; Cortesini R Transplant Proc; 1998 Aug; 30(5):2136-7. PubMed ID: 9723417 [No Abstract] [Full Text] [Related]
4. Role of the indirect recognition pathway in the development of chronic liver allograft rejection. Renna-Molajoni E; Cinti P; Evangelista B; Orlandini AM; Molajoni J; Cocciolo PL; Suciu-Foca N; Cortesini R Transplant Proc; 1998 Aug; 30(5):2140-1. PubMed ID: 9723419 [No Abstract] [Full Text] [Related]
5. Peptide analogues as a strategy to induce tolerance in T cells with indirect allospecificity. Frasca L; Tamir A; Jurcevic S; Marinari B; Monizio A; Sorrentino R; Carbonari M; Piccolella E; Lechler RI; Lombardi G Transplantation; 2000 Aug; 70(4):631-40. PubMed ID: 10972222 [TBL] [Abstract][Full Text] [Related]
6. Inducing unresponsiveness in allopeptide specific T cells: are altered peptide ligands the answer? Jones ND Transplantation; 2000 Aug; 70(4):566-7. PubMed ID: 10972208 [No Abstract] [Full Text] [Related]
7. Indirect T-cell recognition in human allograft rejection. Suciu-Foca N; Liu Z; Colovai AI; Fisher P; Ho E; Reed EF; Rose EA; Michler RE; Hardy MA; Cocciolo P; Gargano F; Cortesini R Transplant Proc; 1997; 29(1-2 /01):1012-3. PubMed ID: 9123174 [No Abstract] [Full Text] [Related]
8. Indirect allorecognition is involved in both acute and chronic allograft rejection. Fluck N; Witzke O; Morris PJ; Wood KJ Transplant Proc; 1999; 31(1-2):842-3. PubMed ID: 10083366 [No Abstract] [Full Text] [Related]
9. T cells specific for viral antigens presented by HLA-Dw4 recognize DR13 on allogeneic cells: a possible mechanism for induction of rejection. Gjertsen HA; Lundin KE; Hansen T; Thorsby E Transplant Proc; 1993 Feb; 25(1 Pt 1):70-1. PubMed ID: 8382384 [No Abstract] [Full Text] [Related]
10. Minor histocompatibility antigens: presentation principles, recognition logic and the potential for a healing hand. Spencer CT; Gilchuk P; Dragovic SM; Joyce S Curr Opin Organ Transplant; 2010 Aug; 15(4):512-25. PubMed ID: 20616723 [TBL] [Abstract][Full Text] [Related]
11. Mapping of dominant HLA-DR determinants recognized via the indirect pathway. Liu Z; Colovai AI; Tugulea S; Reed EF; Harris PE; Maffei A; Molajoni ER; Gargano F; Cortesini R; Hardy MA; Suciu-Foca N Transplant Proc; 1997; 29(1-2):1014-5. PubMed ID: 9123175 [No Abstract] [Full Text] [Related]
12. Significant frequencies of T cells with indirect anti-donor specificity in heart graft recipients with chronic rejection. Hornick PI; Mason PD; Baker RJ; Hernandez-Fuentes M; Frasca L; Lombardi G; Taylor K; Weng L; Rose ML; Yacoub MH; Batchelor R; Lechler RI Circulation; 2000 May; 101(20):2405-10. PubMed ID: 10821818 [TBL] [Abstract][Full Text] [Related]
13. Antagonism of antiviral and allogeneic activity of a human public CTL clonotype by a single altered peptide ligand: implications for allograft rejection. Ely LK; Green KJ; Beddoe T; Clements CS; Miles JJ; Bottomley SP; Zernich D; Kjer-Nielsen L; Purcell AW; McCluskey J; Rossjohn J; Burrows SR J Immunol; 2005 May; 174(9):5593-601. PubMed ID: 15843558 [TBL] [Abstract][Full Text] [Related]
14. [HLA mismatch and graft rejection]. Matsuyoshi H; Senju S; Monji M; Nishimura Y Nihon Rinsho; 2005 Apr; 63 Suppl 4():621-31. PubMed ID: 15861720 [No Abstract] [Full Text] [Related]
15. Mechanism of liver allograft rejection: the indirect recognition pathway. Molajoni ER; Cinti P; Orlandini A; Molajoni J; Tugulea S; Ho E; Liu Z; Suciu-Foca N; Cortesini R Hum Immunol; 1997 Mar; 53(1):57-63. PubMed ID: 9127148 [TBL] [Abstract][Full Text] [Related]
17. Targeting the alloimmune response for prevention of chronic graft loss: efficacy of new immunosuppressive drugs. Eisen HJ Transplant Proc; 1997 Dec; 29(8A):29S-31S. PubMed ID: 9414671 [No Abstract] [Full Text] [Related]
18. CD4+ T Cell Help Is Mandatory for Naive and Memory Donor-Specific Antibody Responses: Impact of Therapeutic Immunosuppression. Chen CC; Koenig A; Saison C; Dahdal S; Rigault G; Barba T; Taillardet M; Chartoire D; Ovize M; Morelon E; Defrance T; Thaunat O Front Immunol; 2018; 9():275. PubMed ID: 29515582 [TBL] [Abstract][Full Text] [Related]
19. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. Kingsley CI; Karim M; Bushell AR; Wood KJ J Immunol; 2002 Feb; 168(3):1080-6. PubMed ID: 11801641 [TBL] [Abstract][Full Text] [Related]
20. Commentary: Priming of alloreactive T cells--where does it happen? Golshayan D; Lechler R Eur J Immunol; 2004 Dec; 34(12):3301-4. PubMed ID: 15484195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]